NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Shumway DA, Corbin KS, Farah MH, et al. Partial Breast Irradiation for Breast Cancer [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2023 Jan. (Comparative Effectiveness Review, No. 259.)
- 1.
- Polgar C, Fodor J, Major T, et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma--5-year results of a randomized trial. Int J Radiat Oncol Biol Phys. 2007 Nov 01;69(3):694–702. doi: 10.1016/j.ijrobp.2007.04.022. PMID: 17531400. [PubMed: 17531400] [CrossRef]
- 2.
- Polgar C, Sulyok Z, Fodor J, et al. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: five-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol. 2002 Jul;80(3):121–8; discussion 129. doi: 10.1002/jso.10110. PMID: 12115793. [PubMed: 12115793] [CrossRef]
- 3.
- Lovey K, Fodor J, Major T, et al. Fat necrosis after partial-breast irradiation with brachytherapy or electron irradiation versus standard whole-breast radiotherapy--4-year results of a randomized trial. Int J Radiat Oncol Biol Phys. 2007 Nov 01;69(3):724–31. PMID: 17524571. [PubMed: 17524571]
- 4.
- Polgar C, Fodor J, Major T, et al. Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial. Radiother Oncol. 2013 Aug;108(2):197–202. doi: 10.1016/j.radonc.2013.05.008. PMID: 23742961. [PubMed: 23742961] [CrossRef]
- 5.
- Polgar C, Major T, Takacsi-Nagy Z, et al. Breast-conserving surgery followed by partial or whole breast irradiation: twenty-year results of a phase 3 clinical study. Int J Radiat Oncol Biol Phys. 2021 Mar 15;109(4):998–1006. doi: 10.1016/j.ijrobp.2020.11.006. PMID: 33186620. [PubMed: 33186620] [CrossRef]
- 6.
- Dodwell DJ, Dyker K, Brown J, et al. A randomised study of whole-breast vs tumour-bed irradiation after local excision and axillary dissection for early breast cancer. Clin Oncol (R Coll Radiol). 2005 Dec;17(8):618–22. doi: 10.1016/j.clon.2005.07.018. PMID: 16372487. [PubMed: 16372487] [CrossRef]
- 7.
- Veronesi U, Orecchia R, Maisonneuve P, et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol. 2013 Dec;14(13):1269–77. doi: 10.1016/S1470-2045(13)70497-2. PMID: 24225155. [PubMed: 24225155] [CrossRef]
- 8.
- Orecchia R, Veronesi U, Maisonneuve P, et al. Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial. Lancet Oncol. 2021 May;22(5):597–608. doi: 10.1016/S1470-2045(21)00080-2. PMID: 33845035. [PubMed: 33845035] [CrossRef]
- 9.
- Livi L, Meattini I, Marrazzo L, et al. Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial. Eur J Cancer. 2015 Mar;51(4):451–63. doi: 10.1016/j.ejca.2014.12.013. PMID: 25605582. [PubMed: 25605582] [CrossRef]
- 10.
- Livi L, Buonamici FB, Simontacchi G, et al. Accelerated partial breast irradiation with IMRT: new technical approach and interim analysis of acute toxicity in a phase III randomized clinical trial. Int J Radiat Oncol Biol Phys. 2010 Jun 01;77(2):509–15. doi: 10.1016/j.ijrobp.2009.04.070. PMID: 19700248. [PubMed: 19700248] [CrossRef]
- 11.
- Meattini I, Saieva C, Marrazzo L, et al. Accelerated partial breast irradiation using intensity-modulated radiotherapy technique compared to whole breast irradiation for patients aged 70 years or older: subgroup analysis from a randomized phase 3 trial. Breast Cancer Res Treat. 2015 Oct;153(3):539–47. doi: 10.1007/s10549-015-3565-2. PMID: 26350524. [PubMed: 26350524] [CrossRef]
- 12.
- Meattini I, Saieva C, Miccinesi G, et al. Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: health-related quality of life final analysis from the Florence phase 3 trial. Eur J Cancer. 2017 May;76:17–26. doi: 10.1016/j.ejca.2017.01.023. PMID: 28262584. [PubMed: 28262584] [CrossRef]
- 13.
- Meattini I, Marrazzo L, Saieva C, et al. Accelerated partial-breast irradiation compared with whole-breast irradiation for early breast cancer: long-term results of the randomized phase III APBI-IMRT-Florence trial. J Clin Oncol. 2020 Dec 10;38(35):4175–83. doi: 10.1200/JCO.20.00650. PMID: 32840419. [PubMed: 32840419] [CrossRef]
- 14.
- Strnad V, Ott OJ, Hildebrandt G, et al. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet. 2016 Jan 16;387(10015):229–38. doi: 10.1016/S0140-6736(15)00471-7. PMID: 26494415. [PubMed: 26494415] [CrossRef]
- 15.
- Ott OJ, Strnad V, Hildebrandt G, et al. GEC-ESTRO multicenter phase 3-trial: accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: early toxicity and patient compliance. Radiother Oncol. 2016 Jul;120(1):119–23. doi: 10.1016/j.radonc.2016.06.019. PMID: 27422584. [PubMed: 27422584] [CrossRef]
- 16.
- Polgar C, Ott OJ, Hildebrandt G, et al. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2017 Feb;18(2):259–68. doi: 10.1016/S1470-2045(17)30011-6. PMID: 28094198. [PubMed: 28094198] [CrossRef]
- 17.
- Schafer R, Strnad V, Polgar C, et al. Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial. Lancet Oncol. 2018 Jun;19(6):834–44. doi: 10.1016/S1470-2045(18)30195-5. PMID: 29695348. [PubMed: 29695348] [CrossRef]
- 18.
- Franceschini D, Loi M, Chiola I, et al. Preliminary results of a randomized study on postmenopausal women with early stage breast cancer: adjuvant hypofractionated whole breast irradiation versus accelerated partial breast irradiation (HYPAB trial). Clin Breast Cancer. 2021 Jun;21(3):231–8. doi: 10.1016/j.clbc.2020.09.004. PMID: 33121891. [PubMed: 33121891] [CrossRef]
- 19.
- Vicini FA, Cecchini RS, White JR, et al. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial. Lancet. 2019 Dec 14;394(10215):2155–64. doi: 10.1016/S0140-6736(19)32514-0. PMID: 31813636. [PMC free article: PMC7199428] [PubMed: 31813636] [CrossRef]
- 20.
- Coles CE, Griffin CL, Kirby AM, et al. Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial. Lancet. 2017 Sep 09;390(10099):1048–60. doi: 10.1016/S0140-6736(17)31145-5. PMID: 28779963. [PMC free article: PMC5594247] [PubMed: 28779963] [CrossRef]
- 21.
- Bhattacharya IS, Haviland JS, Kirby AM, et al. Patient-reported outcomes over 5 years after whole- or partial-breast radiotherapy: longitudinal analysis of the IMPORT LOW (CRUK/06/003) phase III randomized controlled trial. J Clin Oncol. 2019 Feb 01;37(4):305–17. doi: 10.1200/JCO.18.00982. PMID: 30532984. [PMC free article: PMC6357225] [PubMed: 30532984] [CrossRef]
- 22.
- Whelan TJ, Julian JA, Berrang TS, et al. External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial. Lancet. 2019 Dec 14;394(10215):2165–72. doi: 10.1016/S0140-6736(19)32515-2. PMID: 31813635. [PubMed: 31813635] [CrossRef]
- 23.
- Peterson D, Truong PT, Parpia S, et al. Predictors of adverse cosmetic outcome in the RAPID trial: an exploratory analysis. Int J Radiat Oncol Biol Phys. 2015 Apr 01;91(5):968–76. doi: 10.1016/j.ijrobp.2014.12.040. PMID: 25832689. [PubMed: 25832689] [CrossRef]
- 24.
- Olivotto IA, Whelan TJ, Parpia S, et al. Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy. J Clin Oncol. 2013 Nov 10;31(32):4038–45. doi: 10.1200/JCO.2013.50.5511. PMID: 23835717. [PubMed: 23835717] [CrossRef]
- 25.
- Rodriguez N, Sanz X, Dengra J, et al. Five-year outcomes, cosmesis, and toxicity with 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2013 Dec 01;87(5):1051–7. doi: 10.1016/j.ijrobp.2013.08.046. PMID: 24161420. [PubMed: 24161420] [CrossRef]
- 26.
- Li X, Sanz J, Foro P, et al. Long-term results of a randomized partial irradiation trial compared to whole breast irradiation in the early stage and low-risk breast cancer patients after conservative surgery. Clin Transl Oncol. 2021 Oct;23(10):2127–2132.. doi: 10.1007/s12094-021-02618-5. PMID: 33880724. [PubMed: 33880724] [CrossRef]
- 27.
- Song Y-C, Sun G-Y, Fang H, et al. Quality of life after partial or whole-breast irradiation in breast-conserving therapy for low-risk breast cancer: 1-year results of a phase 2 randomized controlled trial. Front Oncol,. 2021;11:738318. doi: 10.3389/fonc.2021.738318. PMID: 34604082. [PMC free article: PMC8480312] [PubMed: 34604082] [CrossRef]
- 28.
- Vaidya JS, Wenz F, Bulsara M, et al. An international randomised controlled trial to compare targeted intraoperative radiotherapy (TARGIT) with conventional postoperative radiotherapy after breast-conserving surgery for women with early-stage breast cancer (the TARGIT-A trial). Health Technol Assess. 2016 Sep;20(73):1–188. doi: 10.3310/hta20730. PMID: 27689969. [PMC free article: PMC5056335] [PubMed: 27689969] [CrossRef]
- 29.
- Vaidya JS, Bulsara M, Baum M, et al. New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer. Br J Cancer. 2021 Aug;125(3):380–389. doi: 10.1038/s41416-021-01440-8. PMID: 34035435. [PMC free article: PMC8329051] [PubMed: 34035435] [CrossRef]
- 30.
- Vaidya JS, Bulsara M, Saunders C, et al. Effect of delayed targeted intraoperative radiotherapy vs whole-breast radiotherapy on local recurrence and survival: long-term results from the TARGIT-A randomized clinical trial in early breast cancer. JAMA Oncol. 2020 Jul 01;6(7):e200249. doi: 10.1001/jamaoncol.2020.0249. PMID: 32239210. [PMC free article: PMC7348682] [PubMed: 32239210] [CrossRef]
- 31.
- Vaidya JS, Bulsara M, Baum M, et al. Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial. BMJ. 2020 Aug 19;370:m2836. doi: 10.1136/bmj.m2836. PMID: 32816842. [PMC free article: PMC7500441] [PubMed: 32816842] [CrossRef]
- 32.
- Vaidya JS, Wenz F, Bulsara M, et al. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet. 2014 Feb 15;383(9917):603–13. doi: 10.1016/S0140-6736(13)61950-9. PMID: 24224997. [PubMed: 24224997] [CrossRef]
- 33.
- Vaidya JS, Joseph DJ, Tobias JS, et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet. 2010 Jul 10;376(9735):91–102. doi: 10.1016/S0140-6736(10)60837-9. PMID: 20570343. [PubMed: 20570343] [CrossRef]
- 34.
- Abo-Madyan Y, Welzel G, Sperk E, et al. Single-center long-term results from the randomized phase-3 TARGIT-A trial comparing intraoperative and whole-breast radiation therapy for early breast cancer. Strahlenther Onkol. 2019 Jul;195(7):640–7. doi: 10.1007/s00066-019-01438-5. PMID: 30796496. [PubMed: 30796496] [CrossRef]
- 35.
- Corica T, Nowak AK, Saunders CM, et al. Cosmetic outcome as rated by patients, doctors, nurses and BCCT.core software assessed over 5 years in a subset of patients in the TARGIT-A trial. Radiat Oncol. 2018 Apr 13;13(1):68. doi: 10.1186/s13014-018-0998-x. PMID: 29653541. [PMC free article: PMC5899392] [PubMed: 29653541] [CrossRef]
- 36.
- Sperk E, Welzel G, Keller A, et al. Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomized phase III trial TARGIT A. Breast Cancer Res Treat. 2012 Aug;135(1):253–60. doi: 10.1007/s10549-012-2168-4. PMID: 22842984. [PubMed: 22842984] [CrossRef]
- 37.
- Corica T, Nowak AK, Saunders CM, et al. Cosmesis and breast-related quality of life outcomes after intraoperative radiation therapy for early breast cancer: a substudy of the TARGIT-A trial. Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):55–64. doi: 10.1016/j.ijrobp.2016.04.024. PMID: 27511847. [PubMed: 27511847] [CrossRef]
- 38.
- Yadav BS, Loganathan S, Sharma SC, et al. Comparison of toxicity and cosmetic outcomes after accelerated partial breast irradiation or whole breast irradiation using 3-dimensional conformal external beam radiation therapy. Adv Radiat Oncol. 2019 Sep 27;5(2):171–9. doi: 10.1016/j.adro.2019.09.005. PMID: 32280816. [PMC free article: PMC7136642] [PubMed: 32280816] [CrossRef]
- 39.
- Bush DA, Slater JD, Garberoglio C, et al. Partial breast irradiation delivered with proton beam: results of a phase II trial. Clin Breast Cancer. 2011 Aug;11(4):241–5. doi: 10.1016/j.clbc.2011.03.023. PMID: 21729673. [PubMed: 21729673] [CrossRef]
- 40.
- Bush DA, Do S, Lum S, et al. Partial breast radiation therapy with proton beam: 5-year results with cosmetic outcomes. Int J Radiat Oncol Biol Phys. 2014 Nov 01;90(3):501–5. doi: 10.1016/j.ijrobp.2014.05.1308. PMID: 25084608. [PubMed: 25084608] [CrossRef]
- 41.
- Galland-Girodet S, Pashtan I, MacDonald SM, et al. Long-term cosmetic outcomes and toxicities of proton beam therapy compared with photon-based 3-dimensional conformal accelerated partial-breast irradiation: a phase 1 trial. Int J Radiat Oncol Biol Phys. 2014 Nov 01;90(3):493–500. doi: 10.1016/j.ijrobp.2014.04.008. PMID: 24880212. [PubMed: 24880212] [CrossRef]
- 42.
- Jacobs DHM, Speijer G, Petoukhova AL, et al. Acute toxicity of intraoperative radiotherapy and external beam-accelerated partial breast irradiation in elderly breast cancer patients. Breast Cancer Res Treat. 2018 Jun;169(3):549–59. doi: 10.1007/s10549-018-4712-3. PMID: 29460031. [PMC free article: PMC5953978] [PubMed: 29460031] [CrossRef]
- 43.
- Jacobs DHM, Horeweg N, Straver M, et al. Health-related quality of life of breast cancer patients after accelerated partial breast irradiation using intraoperative or external beam radiotherapy technique. Breast. 2019 Aug;46:32–9. doi: 10.1016/j.breast.2019.04.006. PMID: 31075670. [PubMed: 31075670] [CrossRef]
- 44.
- Jacobs DHM, Charaghvandi RK, Horeweg N, et al. Health-related quality of life of early-stage breast cancer patients after different radiotherapy regimens. Breast Cancer Res Treat. 2021 Sep;189(2):387–98. doi: 10.1007/s10549-021-06314-4. PMID: 34216316. [PMC free article: PMC8357747] [PubMed: 34216316] [CrossRef]
- 45.
- Jacobs DHM, Mast ME, Horeweg N, et al. Accelerated partial breast irradiation using external-beam or intraoperative electron radiotherapy: 5 year oncological outcomes of a prospective cohort study. Int J Radiat Oncol Biol Phys. 2022 Jul 1;113(3):570–581. doi: 10.1016/j.ijrobp.2022.03.010. PMID: 35301990. [PubMed: 35301990] [CrossRef]
- 46.
- Leonard CE, Wang Y, Asmar L, et al. A prospective phase III trial evaluating patient self-reported pain and cosmesis in accelerated partial breast irradiation utilizing 3-D versus intensity-modulated radiotherapy. Cancer Med. 2021 Oct;10(20):7089–100. doi: 10.1002/cam4.4242. PMID: 34469056. [PMC free article: PMC8525102] [PubMed: 34469056] [CrossRef]
- 47.
- Meszaros N, Major T, Stelczer G, et al. Accelerated partial breast irradiation with 3-dimensional conformal and image-guided intensity-modulated radiotherapy following breast conserving surgery - 7-Year results of a phase II trial. Breast. 2020 Dec;54:222–8. doi: 10.1016/j.breast.2020.10.010. PMID: 33161336. [PMC free article: PMC7648201] [PubMed: 33161336] [CrossRef]
- 48.
- Mutter RW, Jethwa KR, Gonuguntla K, et al. 3 fraction pencil-beam scanning proton accelerated partial breast irradiation: early provider and patient reported outcomes of a novel regimen. Radiat Oncol. 2019 Nov 21;14(1):211. doi: 10.1186/s13014-019-1417-7. PMID: 31752934. [PMC free article: PMC6873533] [PubMed: 31752934] [CrossRef]
- 49.
- Pasalic D, Strom EA, Allen PK, et al. Proton accelerated partial breast irradiation: clinical outcomes at a planned interim analysis of a prospective phase 2 trial. Int J Radiat Oncol Biol Phys. 2021 Feb 01;109(2):441–8. doi: 10.1016/j.ijrobp.2020.09.009. PMID: 32946965. [PubMed: 32946965] [CrossRef]
- 50.
- Shah NM, Tenenholz T, Arthur D, et al. MammoSite and interstitial brachytherapy for accelerated partial breast irradiation: factors that affect toxicity and cosmesis. Cancer. 2004 Aug 15;101(4):727–34. doi: 10.1002/cncr.20424. PMID: 15305402. [PubMed: 15305402] [CrossRef]
- 51.
- Shah C, McGee M, Wilkinson JB, et al. Clinical outcomes using accelerated partial breast irradiation in patients with ductal carcinoma in situ. Clin Breast Cancer. 2012 Aug;12(4):259–63. doi: 10.1016/j.clbc.2012.04.006. PMID: 22658839. [PubMed: 22658839] [CrossRef]
- 52.
- Stecklein SR, Shaitelman SF, Babiera GV, et al. Prospective comparison of toxicity and cosmetic outcome after accelerated partial breast irradiation with conformal external beam radiotherapy or single-entry multilumen intracavitary brachytherapy. Pract Radiat Oncol. 2019 Jan;9(1):e4–e13. doi: 10.1016/j.prro.2018.08.003. PMID: 30125673. [PMC free article: PMC6321793] [PubMed: 30125673] [CrossRef]
- 53.
- Cuttino LW, Arthur DW, Vicini F, et al. Long-term results from the Contura multilumen balloon breast brachytherapy catheter phase 4 registry trial. Int J Radiat Oncol Biol Phys. 2014 Dec 01;90(5):1025–9. doi: 10.1016/j.ijrobp.2014.08.341. PMID: 25442036. [PubMed: 25442036] [CrossRef]
- 54.
- Becherini C, Meattini I, Livi L, et al. External accelerated partial breast irradiation for ductal carcinoma in situ: long-term follow-up from a phase 3 randomized trial. Tumori. 2019 Jun;105(3):205–9. doi: 10.1177/0300891618811278. PMID: 30474504. [PubMed: 30474504] [CrossRef]
- 55.
- Jagsi R, Ben-David MA, Moran JM, et al. Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys. 2010 Jan 01;76(1):71–8. doi: 10.1016/j.ijrobp.2009.01.041. PMID: 19409733. [PMC free article: PMC4414125] [PubMed: 19409733] [CrossRef]
- 56.
- Rehman S, Agarwal R, Ochoa L, et al. Prospective analysis of toxicity in patients treated with strut-adjusted volume implant for early-stage breast cancer. Brachytherapy. 2016 Sep–Oct;15(5):625–30. doi: 10.1016/j.brachy.2016.04.008. PMID: 27263058. [PubMed: 27263058] [CrossRef]
- 57.
- Rabinovitch R, Winter K, Kuske R, et al. RTOG 95-17, a phase II trial to evaluate brachytherapy as the sole method of radiation therapy for stage I and II breast carcinoma-year-5 toxicity and cosmesis. Brachytherapy. 2014 Jan–Feb;13(1):17–22. doi: 10.1016/j.brachy.2013.08.002. PMID: 24041956 [PMC free article: PMC5785096] [PubMed: 24041956] [CrossRef]
- 58.
- Khan AJ, Chen PY, Yashar C, et al. Three-fraction accelerated partial breast irradiation (APBI) delivered with brachytherapy applicators is feasible and safe: first results from the TRIUMPH-T trial. Int J Radiat Oncol Biol Phys. 2019 May 01;104(1):67–74. doi: 10.1016/j.ijrobp.2018.12.050. PMID: 30611839. [PMC free article: PMC7373303] [PubMed: 30611839] [CrossRef]
- 59.
- Jethwa KR, Park SS, Gonuguntla K, et al. Three-fraction intracavitary accelerated partial breast brachytherapy: early provider and patient-reported outcomes of a novel regimen. Int J Radiat Oncol Biol Phys. 2019 May 01;104(1):75–82. doi: 10.1016/j.ijrobp.2018.12.025. PMID: 30583041. [PMC free article: PMC6458060] [PubMed: 30583041] [CrossRef]
- 60.
- Vicini F, Beitsch P, Quiet C, et al. Five-year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial in patients treated with accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2011 Mar 01;79(3):808–17. doi: 10.1016/j.ijrobp.2009.11.043. PMID: 20472364. [PubMed: 20472364] [CrossRef]
- 61.
- Yashar CM, Scanderbeg D, Kuske R, et al. Initial clinical experience with the strut-adjusted volume implant (SAVI) breast brachytherapy device for accelerated partial-breast irradiation (APBI): first 100 patients with more than 1 year of follow-up. Int J Radiat Oncol Biol Phys. 2011 Jul 01;80(3):765–70. doi: 10.1016/j.ijrobp.2010.02.018. PMID: 20646847. [PubMed: 20646847] [CrossRef]
- Appendix References - Partial Breast Irradiation for Breast CancerAppendix References - Partial Breast Irradiation for Breast Cancer
- Sensitivity Analysis - Partial Breast Irradiation for Breast CancerSensitivity Analysis - Partial Breast Irradiation for Breast Cancer
- Preface - Serum Free Light Chain Analysis for the Diagnosis, Management, and Pro...Preface - Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias
- Quality Table - Interventional Treatments for Acute and Chronic Pain: Systematic...Quality Table - Interventional Treatments for Acute and Chronic Pain: Systematic Review
- Introduction - Management of High-Need, High-Cost Patients: A “Best Fit” Framewo...Introduction - Management of High-Need, High-Cost Patients: A “Best Fit” Framework Synthesis, Realist Review, and Systematic Review
Your browsing activity is empty.
Activity recording is turned off.
See more...